Adial Pharmaceuticals ADIL Stock
$3.64
8.982042%
Add to favorites
SECTOR
INDUSTRY
COUNTRY
Exchange
Market Cap
$7.97M
LOW - HIGH [24H]
$3.30
-
$3.69
VOLUME [24H]
$99.98K
P/E Ratio
0
Earnings per share
-$4.89
ISIN
US00688A2050
Adial Pharmaceuticals Price Chart
Adial Pharmaceuticals ADIL Financial and Trading Overview
| Adial Pharmaceuticals stock price | 3.64 USD |
| Previous Close | 3.34 USD |
| Open | 3.41 USD |
| Bid | 3 USD x 100 |
| Ask | 3.08 USD x 100 |
| Day's Range | 3.3 - 3.58 USD |
| 52 Week Range | 1.31 - 11.5 USD |
| Volume | 85.76K USD |
| Avg. Volume | 460.2K USD |
| Market Cap | 7.81M USD |
| Beta (5Y Monthly) | 1.287 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -4.89 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 7 USD |
ADIL Valuation Measures
| Enterprise Value | 2.58M USD |
| Trailing P/E | N/A |
| Forward P/E | -0.2505263 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 1.4494518 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -0.341 |
Trading Information
Adial Pharmaceuticals Stock Price History
| Beta (5Y Monthly) | 1.287 |
| 52-Week Change | -68.19% |
| S&P500 52-Week Change | 18.32% |
| 52 Week High | 11.5 USD |
| 52 Week Low | 1.31 USD |
| 50-Day Moving Average | 2.64 USD |
| 200-Day Moving Average | 4.15 USD |
ADIL Share Statistics
| Avg. Volume (3 month) | 460.2K USD |
| Avg. Daily Volume (10-Days) | 46.14K USD |
| Shares Outstanding | 2.19M |
| Float | 1.34M |
| Short Ratio | 2.49 |
| % Held by Insiders | 4.32% |
| % Held by Institutions | 28.19% |
| Shares Short | 243.62K |
| Short % of Float | 11.19% |
| Short % of Shares Outstanding | 11.12% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:25 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | March 31, 2026 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -108.74% |
| Return on Equity (ttm) | -265.94% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -7549321 USD |
| Net Income Avi to Common (ttm) | -7770762 USD |
| Diluted EPS (ttm) | -4.89 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 4.58M USD |
| Total Cash Per Share (mrq) | 2.14 USD |
| Total Debt (mrq) | 0 USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 3.181 |
| Book Value Per Share (mrq) | 2.463 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -6519611 USD |
| Levered Free Cash Flow (ttm) | -3900587 USD |
Profile of Adial Pharmaceuticals
| Country | United States |
| State | VA |
| City | Glen Allen |
| Address | 4870 Sadler Road |
| ZIP | 23060 |
| Phone | 804 487 8196 |
| Website | https://www.adial.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 5 |
Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment or prevention of addiction and related disorders. The company's lead product is AD04, a serotonin-3 antagonist, which is in Phase 3 clinical trials for the treatment of alcohol use disorder. It is also involved in the development of drug candidates for non-opioid pain reduction and other diseases and disorders. The company was founded in 2010 and is based in Glen Allen, Virginia.
Q&A For Adial Pharmaceuticals Stock
What is a current ADIL stock price?
Adial Pharmaceuticals ADIL stock price today per share is 3.64 USD.
How to purchase Adial Pharmaceuticals stock?
You can buy ADIL shares on the Tech Market Small exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Adial Pharmaceuticals?
The stock symbol or ticker of Adial Pharmaceuticals is ADIL.
Which industry does the Adial Pharmaceuticals company belong to?
The Adial Pharmaceuticals industry is Biotechnology.
How many shares does Adial Pharmaceuticals have in circulation?
The max supply of Adial Pharmaceuticals shares is 2.19M.
What is Adial Pharmaceuticals Price to Earnings Ratio (PE Ratio)?
Adial Pharmaceuticals PE Ratio is now.
What was Adial Pharmaceuticals earnings per share over the trailing 12 months (TTM)?
Adial Pharmaceuticals EPS is -4.89 USD over the trailing 12 months.
Which sector does the Adial Pharmaceuticals company belong to?
The Adial Pharmaceuticals sector is Healthcare.
Adial Pharmaceuticals ADIL included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
|
|
{{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
US Tech Composite
IXIC
US
|
25913.9 USD — |
+2.13
|
10.13B USD — | 25420.35 USD — | 25967.44 USD — | — - | 10.13B USD — |
|
US Tech Capital Market Composite
RCMP
US
|
137.57 USD — |
+2.45
|
— — | 133.6 USD — | 137.82 USD — | — - | — — |
|
US Tech Health Care
IXHC
US
|
1241.31 USD — |
+0.58
|
— — | 1233.81 USD — | 1244.91 USD — | — - | — — |
- {{ link.label }} {{link}}
